Ventria Bioscience

American biotechnology company

File:Ventria-logo.PNG

Logo of Ventria Bioscience

Ventria Bioscience is an American biotechnology company that specializes in the development and commercialization of recombinant proteins derived from plant-based expression systems. The company is known for its innovative use of genetically modified organisms to produce proteins for use in pharmaceuticals, nutraceuticals, and other applications.

History

Ventria Bioscience was founded in 1993 and is headquartered in Fort Collins, Colorado. The company initially focused on developing plant-based systems for producing therapeutic proteins. Over the years, Ventria has expanded its technology platform and product offerings, establishing itself as a leader in the field of plant-made pharmaceuticals.

Technology

Ventria Bioscience utilizes a proprietary technology known as ExpressTec, which involves the use of genetically engineered rice plants to produce recombinant proteins. This method offers several advantages over traditional protein production systems, including lower costs, scalability, and reduced risk of contamination with human pathogens.

Products

The company's product portfolio includes a range of recombinant proteins used in various industries. Notable products include:

• LactoFerrin: A protein with applications in infant formula and dietary supplements.
• Lysozyme: An enzyme used in food preservation and pharmaceuticals.
• Human Serum Albumin: Used in cell culture media and therapeutic applications.

Controversies

Ventria Bioscience has faced criticism and regulatory challenges related to the use of genetically modified crops. Concerns have been raised about the potential environmental impact and the safety of consuming products derived from genetically modified organisms. The company has worked to address these concerns through rigorous testing and compliance with regulatory standards.

Related pages

• Biotechnology
• Genetically modified organism
• Recombinant DNA